Radha Karki

1.7k total citations
27 papers, 1.4k citations indexed

About

Radha Karki is a scholar working on Molecular Biology, Organic Chemistry and Toxicology. According to data from OpenAlex, Radha Karki has authored 27 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 16 papers in Organic Chemistry and 15 papers in Toxicology. Recurrent topics in Radha Karki's work include Cancer therapeutics and mechanisms (19 papers), Bioactive Compounds and Antitumor Agents (15 papers) and Synthesis and biological activity (15 papers). Radha Karki is often cited by papers focused on Cancer therapeutics and mechanisms (19 papers), Bioactive Compounds and Antitumor Agents (15 papers) and Synthesis and biological activity (15 papers). Radha Karki collaborates with scholars based in South Korea, United States and China. Radha Karki's co-authors include Younghwa Na, Youngjoo Kwon, Eung-Seok Lee, Eung-Seok Lee, Yurngdong Jahng, Bhaskar C. Das, Todd Evans, Peter J. Van Veldhuizen, Sasmita Das and Suman Kambhampati and has published in prestigious journals such as Journal of Medicinal Chemistry, European Journal of Medicinal Chemistry and Bioorganic & Medicinal Chemistry.

In The Last Decade

Radha Karki

27 papers receiving 1.4k citations

Peers

Radha Karki

TOXIC

ONCOL

William A. Kinney United States

Pankaj Sharma India

Renukadevi Patil United States

Mirela Sedić Croatia

Vasiliki Sarli Greece

Clemens Zwergel Italy

Jianhui Wu China

Mariusz Mojzych Poland

Ruijuan Liu China

Marcin Cieślak Poland

William A. Kinney United States

Radha Karki

652 ×0.8

911 ×1.3

105 ×0.4

TOXIC

108 ×0.7

ONCOL

95 ×1.0

Citations per year, relative to Radha Karki Radha Karki (= 1×) peers William A. Kinney

Countries citing papers authored by Radha Karki

Since Specialization

Citations

This map shows the geographic impact of Radha Karki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Radha Karki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Radha Karki more than expected).

Fields of papers citing papers by Radha Karki

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Radha Karki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Radha Karki. The network helps show where Radha Karki may publish in the future.

Co-authorship network of co-authors of Radha Karki

This figure shows the co-authorship network connecting the top 25 collaborators of Radha Karki. A scholar is included among the top collaborators of Radha Karki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Radha Karki. Radha Karki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Li, Mengjie, Radha Karki, Moses Bio, et al.. (2017). Folate-PEG Conjugates of a Far-Red Light-Activatable Paclitaxel Prodrug to Improve Selectivity toward Folate Receptor-Positive Cancer Cells. ACS Omega. 2(10). 6349–6360. 38 indexed citations

Karki, Radha, Kyu-Yeon Jun, Tara Man Kadayat, et al.. (2016). A new series of 2-phenol-4-aryl-6-chlorophenyl pyridine derivatives as dual topoisomerase I/II inhibitors: Synthesis, biological evaluation and 3D-QSAR study. European Journal of Medicinal Chemistry. 113. 228–245. 22 indexed citations

Karki, Radha, Tara Man Kadayat, Til Bahadur Thapa Magar, et al.. (2015). Topoisomerase I and II inhibitory activity, cytotoxicity, and structure–activity relationship study of dihydroxylated 2,6-diphenyl-4-aryl pyridines. Bioorganic & Medicinal Chemistry. 23(13). 3638–3654. 39 indexed citations

Park, Chanmi, Kyung-Hwa Jeon, Eun‐Young Lee, et al.. (2015). A Series of Novel Terpyridine-Skeleton Molecule Derivants Inhibit Tumor Growth and Metastasis by Targeting Topoisomerases. Journal of Medicinal Chemistry. 58(3). 1100–1122. 97 indexed citations

Karki, Radha, Chanmi Park, Kyu-Yeon Jun, et al.. (2014). Synthesis, antitumor activity, and structure–activity relationship study of trihydroxylated 2,4,6-triphenyl pyridines as potent and selective topoisomerase II inhibitors. European Journal of Medicinal Chemistry. 84. 555–565. 33 indexed citations

Karki, Radha, et al.. (2014). Synthesis and biological activity of 2,4-di-p-phenolyl-6-2-furanyl-pyridine as a potent topoisomerase II poison. European Journal of Medicinal Chemistry. 90. 360–378. 24 indexed citations

Jun, Kyu-Yeon, Soeun Park, Eun‐Young Lee, et al.. (2014). Discovery of dihydroxylated 2,4-diphenyl-6-thiophen-2-yl-pyridine as a non-intercalative DNA-binding topoisomerase II-specific catalytic inhibitor. European Journal of Medicinal Chemistry. 80. 428–438. 30 indexed citations

Karki, Radha, et al.. (2013). Synthesis and investigation of dihydroxychalcones as calpain and cathepsin inhibitors. Bioorganic Chemistry. 51. 24–30. 10 indexed citations

Das, Bhaskar C., Radha Karki, Sasmita Das, et al.. (2013). Retinoic acid signaling pathways in development and diseases. Bioorganic & Medicinal Chemistry. 22(2). 673–683. 196 indexed citations

10.

Karki, Radha, Tara Man Kadayat, Eun‐Young Lee, et al.. (2012). Design, synthesis, and antitumor evaluation of 2,4,6-triaryl pyridines containing chlorophenyl and phenolic moiety. European Journal of Medicinal Chemistry. 52. 123–136. 58 indexed citations

11.

Karki, Radha, Tara Man Kadayat, Pil-Hoon Park, et al.. (2012). Dihydroxylated 2,4,6-triphenyl pyridines: Synthesis, topoisomerase I and II inhibitory activity, cytotoxicity, and structure–activity relationship study. European Journal of Medicinal Chemistry. 49. 219–228. 68 indexed citations

12.

Karki, Radha, Pil-Hoon Park, Eun‐Young Lee, et al.. (2011). 2,4-Diaryl-5,6-dihydro-1,10-phenanthroline and 2,4-diaryl-5,6-dihydrothieno[2,3-h] quinoline derivatives for topoisomerase I and II inhibitory activity, cytotoxicity, and structure–activity relationship study. Bioorganic Chemistry. 40(1). 67–78. 21 indexed citations

13.

Thapa, Uttam, Radha Karki, Yurngdong Jahng, et al.. (2011). Synthesis of 2,4-diaryl chromenopyridines and evaluation of their topoisomerase I and II inhibitory activity, cytotoxicity, and structure–activity relationship. European Journal of Medicinal Chemistry. 46(8). 3201–3209. 49 indexed citations

14.

Karki, Radha, Mi Jeong Kang, Tae Cheon Jeong, et al.. (2010). Synthesis, topoisomerase I and II inhibitory activity, cytotoxicity, and structure–activity relationship study of hydroxylated 2,4-diphenyl-6-aryl pyridines. Bioorganic & Medicinal Chemistry. 18(9). 3066–3077. 82 indexed citations

15.

Karki, Radha, et al.. (2010). Synthesis, Topoisomerase I and II Inhibitory Activities, and Cytotoxicity of 4,6-Diaryl-2,4'-bipyridine Derivatives. Bulletin of the Korean Chemical Society. 31(6). 1747–1750. 10 indexed citations

16.

Karki, Radha, Byeong‐Seon Jeong, Younghwa Na, et al.. (2010). Synthesis of 2-(thienyl-2-yl or -3-yl)-4-furyl-6-aryl pyridine derivatives and evaluation of their topoisomerase I and II inhibitory activity, cytotoxicity, and structure–activity relationship. Bioorganic & Medicinal Chemistry. 18(6). 2245–2254. 38 indexed citations

17.

Karki, Radha, Uttam Thapa, Yurngdong Jahng, et al.. (2009). 2-Thienyl-4-furyl-6-aryl pyridine derivatives: Synthesis, topoisomerase I and II inhibitory activity, cytotoxicity, and structure–activity relationship study. Bioorganic & Medicinal Chemistry. 18(1). 377–386. 62 indexed citations

18.

Basnet, Arjun, Radha Karki, Byeong‐Seon Jeong, et al.. (2009). 2,6-Dithienyl-4-furyl pyridines: Synthesis, topoisomerase I and II inhibition, cytotoxicity, structure–activity relationship, and docking study. Bioorganic & Medicinal Chemistry Letters. 20(1). 42–47. 46 indexed citations

19.

Basnet, Arjun, Radha Karki, Younghwa Na, et al.. (2007). 2,4,6-Trisubstituted pyridines: Synthesis, topoisomerase I and II inhibitory activity, cytotoxicity, and structure–activity relationship. Bioorganic & Medicinal Chemistry. 15(13). 4351–4359. 115 indexed citations

20.

Thapa, Pritam, et al.. (2007). Depurination of dA and dG Induced by 2-bromopropane at the Physiological Condition. Biomolecules & Therapeutics. 15(4). 224–229. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact